Skip to content
healthcare.dev

NELARABINE

NDC 62332-813, nelarabine, injection, from Alembic Pharmaceuticals Inc..

Product NDC
62332-813
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218554
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
62332-813-50623320813501 VIAL in 1 CARTON (62332-813-50) / 50 mL in 1 VIAL
62332-813-63623320813636 VIAL in 1 CARTON (62332-813-63) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a2a08758-9a9d-49a2-a498-9da109045ee9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62332-813

Use it

Look up 62332-813 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-813 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.